Requirement for RNA-binding activity of MSY2 for cytoplasmic localization and retention in mouse oocytes  by Yu, Junying et al.
Requirement for RNA-binding activity of MSY2 for cytoplasmic
localization and retention in mouse oocytes
Junying Yu,a Norman B. Hecht,b and Richard M. Schultza,*
a Department of Biology, University of Pennsylvania, Philadelphia, PA 19104-6018, USA
b Center for Research on Reproduction and Women’s Health, University of Pennsylvania, Philadelphia, PA 19104, USA
Received for publication 19 July 2002, revised 26 November 2002, accepted 26 November 2002
Abstract
MSY2, a mouse germ cell-specific Y-box protein, is implicated in the global regulation of the stability and/or translation of maternal
mRNAs in the mouse oocyte. We report here that in the oocyte 75% of MSY2 protein is associated with a Triton-insoluble preparation,
whereas in either male germ cells or when exogenously expressed in transfected somatic cells almost all MSY2 is soluble. This retention
in the oocyte, which is unlikely mediated either by microfilaments or by microtubules, markedly decreases beyond the two-cell stage of
development. By microinjecting mutant MSY2-EGFP chimeric mRNAs into mouse oocytes and then assaying the expressed protein’s
localization by laser-scanning confocal microscopy, we find that an intact cold-shock domain (CSD), containing two RNA-binding motifs,
is required to localize MSY2 to the oocyte cytoplasm. In addition, an additional basic/aromatic amino acid island (B/A), which can also
interact with RNA, in the C-terminal tail domain is necessary to retain MSY2 following Triton permeabilization. Intact mRNA appeared
required for this retention, since RNase A treatment of Triton-permeabilized oocytes or microinjection of RNase A into the oocyte released
essentially all of the endogenous MSY2 protein. Furthermore, there is a positive correlation between the ability of the mutant MSY2-EGFP
protein to remain associated with the Triton-insoluble preparations and its increased affinity for RNA, as determined by RNA electrophoretic
mobility shift assays. These results suggest that binding of intact maternal mRNA by MSY2 is required for its cytoplasmic retention.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Mammalian oocytes are highly specialized cells. During
the prolonged growth phase that occurs over the course of
20 days, oocyte volume increases 200- to 300-fold and
the oocyte accumulates large quantities of mRNA in the
cytoplasm; the fully grown oocyte contains 80 pg of
mRNA and 350–500 pg of total RNA (Bachvarova, 1985
and references therein). The mRNA present in the nonpoly-
somal fraction and presumably not translated is extremely
stable, whereas the translated mRNAs have a half-life of6
days (Bachvarova, 1985); the total maternal mRNA pool in
the growing oocyte is very stable (t1/28–12 days) (Brower
et al., 1981). This remarkable stability is likely a major
factor that permits mRNA accumulation during the growth
phase, since there is no evidence for enhanced rates of
transcription (Bachvarova, 1985). Little is known, however,
regarding the mechanism(s) that confers stability to mater-
nal mRNAs and their translational repression in the growing
oocyte due to the limited quantities of biological material.
Proteins that package maternal mRNAs into mRNP parti-
cles, of which Y-box proteins are found to be the major
component, are implicated in regulating their stability
and/or translation in nonmammalian oocytes (Matsumoto
and Wolffe, 1998; Sommerville, 1999).
Y-box proteins are highly conserved multifunctional pro-
teins that can regulate both transcription and translation (Ma-
tsumoto and Wolffe, 1998; Sommerville, 1999; Wolffe, 1994).
Generally, these proteins consist of a variable N-terminus, a
highly conserved cold-shock domain (CSD), and a C-terminal
tail domain (Sommerville and Ladomery, 1996; Wolffe, 1994).
* Corresponding author. Department of Biology, University of Penn-
sylvania, 415 South University Avenue, Philadelphia, PA 19104-6018.
Fax: 1-215-898-8780.
E-mail address: rschultz@mail.sas.upenn.edu (R.M. Schultz).
R
Available online at www.sciencedirect.com
Developmental Biology 255 (2003) 249–262 www.elsevier.com/locate/ydbio
0012-1606/03/$ – see front matter © 2003 Elsevier Science (USA). All rights reserved.
doi:10.1016/S0012-1606(02)00094-5
The variable N-terminus is thought to confer differences in
functional specificity to different members. The CSD has two
RNA-binding motifs (RNP-1 and RNP-2), which are respon-
sible for the protein’s specificity for the Y-box (or reverse
CCAAT box) present in the promoter of many genes. The
C-terminal tail domain contains four islands of basic/aromatic
amino acids (B/A) surrounded by acidic regions, which contain
potential sites for serine/threonine phosphorylation. This C-
terminal domain is involved in nonspecific nucleic acid bind-
ing and protein–protein interactions. In addition, some Y-box
family members can interact with cytoskeletal structures such
as microfilaments (and possibly microtubules) (Ruzanov et al.,
1999) via their aminoterminal domain, suggesting that they
may also function in the subcellular localization or transport of
mRNAs.
In Xenopus oocytes, the germ-line Y-box protein FRGY2
packages nonspecifically 80% of maternal mRNAs into
mRNP particles that are not translated (Davidson, 1986).
MSY2, which is the mouse homolog of FRGY2, is ex-
pressed only in germ cells (Gu et al., 1998). In male germ
cells, MSY2 is present in the nonpolysomal mRNP parti-
cles, which packages 75% of total paternal mRNAs in
round spermatids (Gold and Hecht, 1981; Gold et al., 1983;
Hecht, 1998). In oocytes, MSY2 is one of the most abundant
proteins, representing 2% of the total oocyte protein (Yu
et al., 2001). In vitro studies suggest that MSY2 binds
full-length mRNAs with relatively little sequence-specific-
ity and is capable of moderately repressing the translation of
mRNAs in rabbit reticulate lysates when present at a pro-
tein/RNA molar ratio similar to that in the oocyte (Yu et al.,
2002). These data suggest that MSY2 plays a global role in
regulating the stability and/or translation of maternal
mRNAs. Surprisingly, unlike MSY2 in the male germ cells
where the protein is soluble, the majority of MSY2 in the
oocyte (75%) is associated with a Triton-insoluble prepara-
tion (Yu et al., 2001). This association suggests that MSY2
sequesters maternal mRNAs from the translation machinery
and thereby confers mRNA stability.
To test the hypothesis that the RNA-binding activity of
MSY2 is essential for its resistance to detergent extraction,
we performed a deletion and mutation analysis of MSY2.
We report here that both an intact CSD and a B/A island are
required to retain MSY2 in the oocyte cytoplasm following
Triton permeabilization, i.e., the RNA-binding activity is
essential. Moreover, this retention requires intact maternal
mRNA and is lost during preimplantation development.
Materials and methods
Collection and culture of mouse oocytes and
preimplantation embryos
Fully grown mouse oocytes (78 m in diameter) were
collected from adult CF-1 mice (6 weeks old) as previ-
ously described (Temeles et al., 1994). The oocytes were
cultured in the bicarbonate-containing minimal essential
medium (Earle’s salts) containing pyruvate (100 g/ml),
gentamicin (10 g/ml), polyvinylpyrrolidone (3 mg/ml),
and 25 mM Hepes, pH 7.2 (MEM/PVP  bicarbonate) in
the presence of 0.2 mM 3-isobutyl-1-methylxanthine
(IBMX) to inhibit oocyte maturation in an atmosphere of
5% CO2 at 37°C. The zona pellucida (ZP) was removed by
briefly incubating oocytes in acidic Tyrode solution (pH
2.5). To disrupt either microfilaments or microtubules, oo-
cytes were incubated in MEM/PVP  bicarbonate contain-
ing cytochalasin D (5 g/ml) or nocodazole (10 g/ml),
respectively, for 1 h at 37°C.
One-cell embryos were obtained from superovulated
CF-1 mice that were mated with B6D2 males (Jackson
Laboratory, West Grove, PA) as previously described (Yu
et al., 2002). Embryos were cultured in KSOM (Ho et al.,
1995) in an atmosphere of 5% O2/5% CO2/90% N2 at 37°C.
Preparation of mouse male germ cells
The testes from an adult CD-1 mouse were decapsulated
and incubated in 4 ml of RPMI 1640 medium (Invitrogen,
Carlsbad, CA) containing 2.5 mg of collagenase (Sigma, St.
Louis, MO) at 34°C for 15 min. The medium was removed
and the cells were washed once with RPMI 1640 and then
incubated in 4 ml RPMI 1640 containing 2.5 mg trypsin and
10 g DNase I at 34°C for 20 min (Sigma). Tubules re-
leased from the testes were dispersed by pipetting. After
addition of trypsin inhibitor (3 mg) and DNase I (10 g),
cells were collected by centrifugation at 80g for 5 min and
washed twice with RPMI 1640 with 0.5% BSA.
Cytoskeletal preparation
To determine the association of MSY2 with the cytoskel-
etal fraction, oocytes/embryos were treated with 0.1% Tri-
ton X-100 containing 100 mM KCl, 5 mM MgCl2, 3 mM
EGTA, 20 mM Hepes, pH 6.8, and 1% BSA (intracellular
buffer, ICB) for 10 min at room temperature. For immuno-
blot analysis, oocytes treated with Triton X-100 were
washed three times with ICB and dissolved directly in 2
SDS–PAGE sample buffer prior to immunoblot analysis
(Yu et al., 2001). Alternatively, oocytes were resuspended
in hypotonic buffer (10 mM Tris–HCl, pH 7.6, 10 mM KCl.
1.5 mM MgCl2, 0.5 mM DTT, 0.2 mM pepstatin A, 1 g/ml
aprotinin, 1 g/ml leupepstatin, and 0.2 mM PMSF), fol-
lowed by homogenization. The samples were centrifuged at
16,000g at 4°C for 20 min, and both the supernatant and the
pellet were dissolved in the SDS–PAGE sample buffer for
immunoblot analysis.
For male germ cells, following incubation with Triton
X-100 or homogenization, the samples were centrifuged at
16,000g at 4°C for 20 min. The pellet was washed three
times with ICB. The supernatant, the first washing, and the
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pellet were dissolved in 2 SDS–PAGE sample buffer for
immunoblot analysis.
Transfection of NIH 3T3 cells
To make MSY2-EGFP and EGFP transfection con-
structs, the EcoRI/NotI fragment from pXT7-MSY2-EGFP
(Yu et al., 2001) was cloned into the same restriction sites
in the pEGFP-N2 vector (Clontech, Palo Alto, CA). The
NheI/NotI fragment containing MSY2-EGFP or EGFP
alone was then cloned into the pRL-CMV vector (Promega,
Madison, WI). EGFP served as the control.
Transfection of NIH 3T3 somatic cells was carried out
essentially as described in the manual for the Fugene 6
transfection reagent (Roche Diagnostics Corp., Indianapo-
lis, IN). Briefly, about 106 freshly passaged NIH 3T3 cells
in 10 ml DMEM/10% FBS (Mediatech; Fisher Scientific,
Pittsburgh, PA) were used to seed each 100-mm plate. For
transfection, 6 g of pRL-CMV-EGFP or pRL-CMV-
MSY2-EGFP DNA was mixed with 18 l Fugene 6 reagent
in 570 l serum-free medium and incubated for 45 min at
room temperature before addition to cells that had been
cultured overnight. Twenty-six hours later, the transfected
cells, which were washed three times with 5 ml PBS, were
scraped off the plates into 1 ml PBS and then pelleted by
centrifugation for 10 s at maximum speed in an Eppendorf
microfuge. The cells were resuspended in 1 ml ice-cold
PBS, divided into four equal fractions, and then pelleted by
centrifugation. To assay the solubility of MSY2 protein, the
cells were reuspended in 50 l of 0.1 or 0.5% Triton X-100
in ICB and incubated for 10 min at room temperature before
centrifugation at 16,000g at 4°C for 20 min. The supernatant
and pellet fractions were then used for immunoblotting
analysis for MSY2 (see below).
Generation of mutant MSY2-EGFP chimeric mRNAs
Mutant msy2 cDNAs were inserted into the EcoRI/EagI
sites of the EGFP-pXT7 control construct (Yu et al., 2001)
where the restriction sites after the EGFP coding region
(NotI, XbaI, EcoRI, XhoI, BglII, EcoRV, SpeI) have been
deleted; the pXT7 vector was a generous gift from Sergei
Sokol, Harvard University. All the msy2 cDNAs were ob-
tained by PCR reactions from full-length msy2 cDNA using
Pfu polymerase (Stratagene, La Jolla, CA). The PCR con-
ditions were as previously described (Yu et al., 2001). All
the primers used are listed in Tables 1 and 2. For constructs
1 to 30 (except 17–19, 21–24, and 30), the PCR products
were directly cloned into the EcoRI/EagI sites of EGFP-
pXT7 vector. To make constructs 16 to 19, the CSDTaiLF/
R12R fragment was removed from EGFP-pXT7 vector by
digesting with EagI and then filling the end with Klenow
fragment (Promega), followed by HindIII digestion. The
cDNAs were then inserted into the HindIII/EcoRI sites of
constructs 25 to 28, respectively, in which the constructs
were digested with EcoRI and the 5 protruding ends were
then removed with Mung Bean Nuclease (Amersham, Pis-
cataway, NJ), followed by HindIII digestion. Similarly, con-
structs 20 to 23 were made by inserting the LMSY2F/R12R
fragments (HindIII/EagI) into the HindIII/EcoRI sites of
constructs 25 to 28; construct 24 was made by inserting the
N-terminus HindIII/EagI fragment into the HindIII/EcoRI
sites of construct 25, and constructs 29 and 30 were made by
inserting the HindIII/EagI fragments from construct 10 and
28 into the HindIII/EcoRI sites of construct (BA2F (-NLS)/
LMSY2R)-EGFP-pXT7. To make the site-mutagenesis
construct PM1 (construct 31), LMSY2F/RNP1R and
RNP1F/LMSY2R PCR products were gel-purified. The
full-length PM1 cDNA was obtained by a second PCR
reaction with primers LMSY2F/LMSY2R, and 0.5 l each
of purified LMSY2F/RNP1R and RNP1F/LMSY2R PCR
products was used as template. The PM1 cDNA was puri-
fied from the gel and cloned into the EcoRI/EagI sites of
EGFP-pXT7. Similarly, construct PM2 (32) was made with
primers LMSY2F, RNP2R, RNP2F, and LMSY2R, and
construct PM12 (33) was made with primers LMSY2F,
RNP12R, RNP2F, and LMSY2R; for PM12, PM1 cDNA
was used as template in the first round of PCR reactions.
All the constructs were linearized with SacI, and in vitro
transcription reactions were carried out with T7 RNA poly-
merase as previously described (Yu et al., 2001).
Microinjection
Oocytes and embryos were microinjected with 5 to 10 pg
of each MSY2-EGFP chimeric mRNA as previously de-
scribed (Yu et al., 2001); one blastomere of each two-cell
embryo was injected. The injected oocytes were cultured
overnight in MEM/PVP ( bicarbonate and IBMX) and the
injected embryos were cultured in KSOM as described
above.
Immunocytochemistry and laser-scanning confocal
microscopy
Immunocytochemical detection of endogenous MSY2
was performed as previously described (Yu et al., 2001),
except that the primary antibody used was -MSY2 (1:4000
dilution); -MSY2 is an affinity-purified polyclonal anti-
body raised against recombinant MSY2 (Yu et al., 2002).
The secondary antibody was Alexa Fluor 488 goat anti-
rabbit (2 mg/ml stock solution used at a 1:500 dilution;
Molecular Probes, Eugene, OR). Phalloidin-TRITC (1:100
dilution, Sigma) was incubated together with the secondary
antibody for actin staining. The samples were then visual-
ized by laser-scanning confocal microscopy using a Leica
confocal microscope.
Oocytes expressing mutant MSY2-EGFP were examined
by laser-scanning confocal microscopy. The cells were
fixed with 3.7% paraformaldehyde for 20 min at room
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temperature. To determine the association of MSY2 with
the oocyte Triton X-100 insoluble fraction, some oocytes
were treated with 0.1% Triton X-100 for 10 min at room
temperature as previously described (Yu et al., 2001). All
the microinjections were repeated at least twice and typi-
cally at least five oocytes were examined.
RNase A treatment
To check whether RNA integrity was required for the
retention of MSY2 following Triton permeabilization,
oocytes were incubated with different concentrations
of RNase A (diluted in ICB buffer, stock 10 mg/ml
boiled for 15 min in 10 mM Tris–HCl, pH 7.5, 15 mM
NaCl; Boehringer Mannheim, Indianapolis, IN) for 30
min at 37°C following permeabilization with 0.1% Triton
X-100 as described above. Alternatively, about 40 pg
RNase A was microinjected into each oocyte followed by
a 30-min incubation at 37°C prior to Triton X-100 per-
meabilization.
Reverse transcription (RT)-PCR
RNA was extracted and reverse transcribed as previously
described (Temeles et al., 1994). In each case, rabbit globin
mRNA (0.05 pg /oocyte) was added prior to RNA extraction
to normalize for RNA extraction and reverse transcription
reaction efficiency. For each set of gene-specific primers,
the linear region of semi-log plots of the amount of PCR
product as a function of the cycle number was determined.
The cycle numbers selected for -globin mRNA (34), Spin
(28), Mos (33), and Plat (33) were in the linear region. RNA
isolated from 20 oocytes was reverse-transcribed using ran-
dom hexamers. For the PCR reactions, five oocyte equiva-
lents of cDNA were used as template for each set of primers
(Table 2). The PCR amplification conditions were as fol-
lows: an initial denaturation at 94°C for 5 min, followed by
the corresponding number of cycles of 94°C for 15 s, 55°C
for 30 s and 72°C for 1 min, followed by 72°C for 5 min.
The PCR products were run on a 1.5% agarose gel and
stained with ethidium bromide.
Table 1
Description of constructs and primers used to generate constructs used for deletion and mutation analyses
No. Name 5 primer1 3 primer1 5 primer2 3 primer2
1 MSY2 LMSY2F LMSY2R
2 NCSDTail3 LMSY2F CSDTAIL3R
3 NCSDTail2 LMSY2F CSDTAIL2R
4 NCSDTail1 LMSY2F CSDTAIL1R
5 NCSD LMSY2F NCSDR
6 N-terminus LMSY2F NR
7 CSDTAIL4 CSDTAILF LMSY2R
8 CSDTAIL3 CSDTAILF CSDTAIL3R
9 CSDTAIL2 CSDTAILF CSDTAIL2R
10 CSDTAIL1 CSDTAILF CSDTAIL1R
11 CSD CSDTAILF NCSDR
12 1/2CSDTAIL4 1/2CSDTAILF LMSY2R
13 1/2CSDTAIL3 1/2CSDTAILF CSDTAIL3R
14 1/2CSDTAIL2 1/2CSDTAILF CSDTAIL2R
15 1/2CSDTAIL1 1/2CSDTAILF CSDTAIL1R
16 R12Tail4 CSDTAILF R12R
17 R12Tail3
18 R12Tail2
19 R12Tail1
20 NR12Tail4 LMSY2F R12R
21 NR12Tail3
22 NR12Tail2
23 NR12Tail1
24 NTAIL4
25 Tail4 TAILF LMSY2R
26 Tail3 TAILF CSDTAIL3R
27 Tail2 TAILF CSDTAIL2R
28 Tail1 TAILF CSDTAIL1R
29 CSDTail134 BA2F(-NLS) LMSY2R
30 Tail134
31 PM1 LMSY2F RNP1R RNP1F LMSY2R
32 PM2 LMSY2F RNP2R RNP2F LMSY2R
33 PM3 LMSY2F RNP12R RNP2F LMSY2R
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Immunoblotting
Oocyte extracts were run on a 9% SDS–PAGE gel
and transferred to Immobilon P (Millipore, Bedford,
MA) as previously described (Yu et al., 2001). The mem-
branes were blocked with 1 TBS/0.1% Tween 20/5%
nonfat milk (1 TBS: 25 mM Tris–HCl, 150 mM NaCl,
pH 7.3) for 1 h at room temperature. After blocking,
the membranes were washed twice in TBST (0.1% Tween
20) for 5 min each. The membranes were then incubated
with -MSY2 (1:2000 diluted in TBST/5%BSA) for 1 h
at room temperature. Following incubation with the pri-
mary antibody, the membranes were washed three times
in TBST for 5 min each. The membranes were then
incubated with donkey anti-rabbit AP-conjugated sec-
ondary antibody (stock 0.8 mg/ml, 1:5000 dilution in
blocking buffer; Jackson Laboratory) for 1 h at room
temperature. After washing in TBST three times (5 min
each), the membranes were developed with ECF
substrate (Amersham), and scanned with a Storm 860
system.
Generation of recombinant MSY2 proteins
The cDNAs for NCSD (primers 18/21), NCSDTAIL1
(primers 18/20), PM1 (primers 18/19), and MSY2 (primers
18/19) were cloned into the NdeI/EagI sites of pET-28a ()
(Table 2) (Novagen, Madison, WI). Recombinant proteins
bearing a His tag at the N-terminus were expressed and
purified as previously described (Yu et al., 2001). The purity
for these recombinant proteins, which were used for RNA
electrophoretic mobility shift assays, was estimated to be
about 60, 90, 30, and 80%, respectively.
RNA electrophoretic mobility shift assay (EMS)
The protamine 1 (Prm1) full-length cDNA was amplified
from a testis cDNA (Primer Prm1F and Prm1R, Table 2)
and cloned into the HindIII/BamH1 sites of pSP64
(poly(A)) (Promega). For in vitro transcriptions, the pSP64
(poly(A)) plasmids were linearized with EcoRI.
The in vitro transcription reactions were carried out as
described in the SP6 MAXIscript kit (Ambion, Austin, TX).
Table 2
Sequence of primers used for plasmid construction
No. Name Sequence
1 LMSY2F 5A/TCC/GAA/TTC/ATG/AGC/GAG/GCG/GAG/GCG/T3
2 LMSY2R 5A/GAG/CGG/CCG/CTC/CAG/TAT/GGT/GGT/GGG3
3 NCSDR 5A/GAG/CGG/CCG/CAC/TGG/TAC/CCC/CCC/AGG/CCC3
4 TAILF 5TCC/GAA/TTC/ATG/AGC/AAG/GGC/AGC/CGC/TAT/GCC/CCT3
5 NR 5A/GAG/CGG/CCG/GTC/CGC/CTG/ACT/CCG/GGC/CGG3
6 CSDTAILF 5TCC/GAA/TTC/ATG/AGC/AAG/CCG/GTG/CTG/GCA/ATC/CAA3
7 CSDTAIL3R 5A/GAG/CGG/CCG/GGG/CTC/AGG/CCG/GGA/GCC/ATC3
8 CSDTAIL2R 5A/GAG/CGG/CCG/TTC/ATC/TCC/CTG/CTG/TTG/ATC3
9 CSDTAIL1R 5A/GAG/CGG/CCG/CCC/CGA/GTC/CTC/TGC/CCG/CTC3
10 1/2CSDTAILF 5TCC/GAA/TTC/ATG/AGC/AAG/AGA/AAC/AAC/CCC/AGG/AAG3
11 BA2F(-NLS) 5TCC/GAA/TTC/CCC/AAC/CAG/CAA/CAG/CCC/ATA3
12 R12R 5A/GAG/CGG/CCG/AAT/AGC/TGT/CTG/GTG/AAC/AAA3
13 RNP1R 5TGT/TGA/TGG/CTC/CGG/CAC/CAT/TCC/GGA/CGT/TGA/ACC3
14 RNP1F 5TGG/TGC/CGG/AGC/CAT/CAA/CAG/GAA/TGA/CAC/CAA3
15 RNP2R 5GAC/GGC/CTC/CTT/GGT/GGC/ATT/CCT/GTT/GAT/GAA/TCC/GTA3
16 RNP12R 5GAC/GGC/CTC/CTT/GGT/GGC/ATT/CCT/GTT/GAT/GGC/TCC/GGC3
17 RNP2F 5AAT/GCC/ACC/AAG/GAG/GCC/GTC/TTT/GTT/CAC/CAG/ACA/GCT3
18 NdeI-MSY2F 5GGA/ATT/CCA/TAT/GAG/CGA/GGC/GGA/GGC/GT3
19 MSY2R(stop) 5A/GTG/CGG/CCG/TCA/CTC/CAG/TAT/GGT/GGT3
20 NCSDTAIL1(stop) 5A/GAG/CGG/CCG/TCA/CCC/CGA/GTC/CTC/TGC/CCG/CTC3
21 NCSD(stop) 5A/GAG/CGG/CCG/TCA/CAC/TGG/TAC/CCC/CCC/AGG/CCC3
22 -Globin A 5GCA/GCC/ACG/GTG/GCG/AGT/AT3
23 -Globin B 5GTG/GGA/CAG/GAG/CTT/GAA/AT3
24 MosF 5CCA/TCA/AGC/AAG/TAA/ACA/AG3
25 MosR 5AGG/GTG/ATT/CCA/AAA/GAG/TA3
26 PlatF 5CAT/GGG/CAA/GAG/TTA/CAC/AG3
27 PlatR 5CAG/AGA/AGA/ATG/GAG/ACG/AT3
28 spindlinF 5GTG/TGT/CGC/TGG/GAA/GGT/CA3
29 spindlinR 5GCC/AAG/CCT/CTG/GTG/TTT/GC3
30 Prm1F 5TAC/AAG/CTT/ACA/GCC/CAC/AAA/ATT/CCA/CCT3
31 Prm1R 5CGC/GGA/TCC/TTG/TTC/CTT/AGC/AGG/CTC/CT3
Note. The underlined letters indicate the following restriction sites: GAATTC: EcoRI: CGGCCG: EagI; AAGCTT: HindIII; GGATCC: BamHI.
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The probe was extracted once with phenol/chloroform, and
once with chloroform, and then precipitated by adding 0.1
vol 5 M ammonium acetate and 1 vol isopropanol. The
sample was chilled at 20°C for 30 min and the precipi-
tated material was collected by centrifugation at 14,000g for
20 min at 4°C. The pellet was washed with 75% ethanol
twice and resuspended in RNase-free H2O.
Gel-shift assays were carried out in 20 l containing 1
binding buffer (20 mM Hepes, pH 7.9, 2 mM MgCl2, 100
mM KCl, 1 mM DTT, and 24 g/ml BSA); about 0.25 
106 cpm of prm1 full-length RNA probe was used in the
reactions (Yu et al., 2002). The reaction mixtures were
incubated at room temperature for 20 min and then run on
a 4% nondenaturing 37.5:1 acrylamide gel (0.5 TBE: 45
mM Tris base, 50 mM boric acid, 1 mM EDTA). The gels
were vacuum dried, exposed on a phosphorimager cassette,
and scanned with a Storm 860 system.
Results
MSY2 retention in oocytes, male germ cells, and somatic
cells
The majority of MSY2 (75%) in the oocytes is asso-
ciated with a Triton X-100 insoluble fraction under condi-
tions that release 80% of the oocyte protein (Yu et al.,
2001), including ribosomes as assessed by the release of
ribosomal protein S6 (data not shown); hereafter Triton
X-100 will be referred to as Triton. In that study, MSY2
retention was assayed in ZP-intact oocytes. Because some
of the experiments described here required that the ZP be
removed, we first demonstrated that the amount of retained
MSY2 detected by immunoblotting was very similar in
ZP-intact and ZP-free oocytes following Triton permeabi-
lization (data not shown). In addition, most of the MSY2
was present in the pellet following homogenization of ZP-
free oocytes in hypotonic buffer and centrifugation at
16,000g for 20 min (Fig. 1A). Thus, MSY2 in oocytes was
insoluble following two different types of treatments to
prepare soluble and insoluble fractions. The Triton-insolu-
ble preparations contain cytoskeletal components and the
aminoterminal portion of the Y-box protein YB-1 interacts
with microfilaments and possibly microtubules (Ruzanov et
al., 1999). Neither of these systems, however, mediated the
retention of MSY2, because neither cytochalasin D nor
nocodazole treatment prior to Triton permeabilization af-
fected the amount of MSY2 retained as determined by
immunoblotting (Fig. 1B).
To ascertain if MSY2 was retained in male germ cells
following Triton permeabilization, male germ cells were
permeabilized with Triton in a similar fashion as oocytes, or
subjected to hypotonic buffer treatment followed by homog-
enization. In each case, following centrifugation the relative
amount of MSY2 in the supernatant and pellet fractions was
assayed by immunoblotting. Results of these experiments
indicated that in contrast to the oocyte,90% of male germ
cell MSY2 was soluble (Fig. 2A). Similarly, when MSY2
was expressed in somatic cells that were then treated with
Triton and centrifuged, 80% of the MSY2 was present in
the soluble fraction (Fig. 2B). Thus, MSY2 retention fol-
lowing Triton permeabilization appears unique to the oo-
cyte.
Developmental change in MSY2 retention
To ascertain if cytoplasmic retention of MSY2 in the
oocyte following permeabilization was lost or retained dur-
ing preimplantation development, we examined the reten-
tion of exogenously expressed MSY2-EGFP, because en-
dogenous MSY2 is degraded by the late two-cell stage (Yu
et al., 2001). In these experiments, early one-cell embryos
were microinjected with MSY2-EGFP mRNA or EGFP
mRNA, which served as controls, and the embryos were
then cultured to the late one-cell or two-cell stage. Simi-
larly, one blastomere of each two-cell embryo was injected,
and the embryos were cultured to the four-cell and eight-cell
stages. Following culture, the embryos were either fixed or
permeabilized with Triton (Fig. 3). Although the bulk of
MSY2 was retained following permeabilization of one- and
two-cell embryos, there was a pronounced decrease in the
amount retained by the four-cell stage, and little, if any, was
retained by the eight-cell stage. In all cases, expressed
EGFP was totally soluble following permeabilization. Thus,
the factor(s) responsible for MSY2 retention in the oocyte
appears either lost or modified during preimplantation de-
velopment.
Fig. 1. Immunoblot analysis of MSY2 (A) following homogenization and
centrifugation and (B) retention following Triton permeabilization of cy-
tochalasin- and nocodazole-treated oocytes. (A) ZP-free oocytes (28) were
homogenized prior to centrifuation. T, total, no homogenization; S, super-
natant; P, pellet. The experiment was performed twice; similar results were
obtained each time, and shown are the results of one experiment. (B)
Twenty oocytes were used in each lane. None: no treatment; T: Triton
X-100 permeabilization alone; N/T: Nocodazole treatment followed by
Triton permeabilization; C/T: Cytochalasin D treatment followed by Triton
X-100 permeabilization; N/C/T: Nocadazole and Cytochalasin D treatment
followed by Triton X-100 permeabilization. The experiment was per-
formed twice; similar results were obtained each time, and shown are the
results of one experiment.
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Requirement for RNA-binding activity of MSY2 for
cytoplasmic retention following Triton permeabilization
Two distinct mechanisms can be envisioned for the cy-
toplasmic retention of MSY2 that is observed following
Triton permeabilization. The first is that MSY2 is already
insoluble and associates with mRNAs following their entry
into the cytoplasm. This model predicts that the RNA-
binding activity of MSY2 is unlikely required for its cyto-
plasmic retention following Triton permeabilization. The
second model posits that MSY2 binds mRNA and that this
binding leads to MSY2 being resistant to detergent extrac-
tion. This model predicts that MSY2 mutants with reduced
RNA-binding affinity for RNA will not be retained as well
as wild-type MSY2 following Triton permeabilization. A
deletion and site-mutagenesis analysis was therefore under-
taken to dissect what domains of MSY2 may be required for
its cytoplasmic retention.
Various mutant MSY2-EGFP chimeric mRNAs were
microinjected into the oocyte cytoplasm and after an over-
night incubation the oocytes were either fixed directly or
permeabilized with Triton and then fixed before examina-
tion by laser-scanning confocal microscopy (Fig. 4 and
Table 3 ). In these experiments, we noted that expression of
the wild-type MSY2-EGFP fusion protein, based on fluo-
rescence intensity, was higher than or similar to that ob-
tained following injection of any of the mutant chimeric
mRNAs (data not shown). This minimized the likelihood
that some of the changes in localization described below,
e.g., the protein was also present in the nucleus, were due to
the more efficient expression of the protein from these
chimeric mRNAs such that the “surplus” protein surpasses
the ability of the cytoplasm to retain it.
The aminoterminus was not required for association with
the Triton-insoluble preparation, since similar to MSY2,
CSDTail4 was localized to the cytoplasm and retained fol-
lowing permeabilization. The aminoterminus, however,
may interact in some manner with the CSD to help retain
MSY2 in the cytoplasm. When the second half of the CSD
was deleted, the expressed protein was partially retained in
the cytoplasm following permeabilization (compare con-
structs 16–19 with 20–23, except 22 in Table 3). In the
abence of the aminoterminus, when either the first half or
the second half of the CSD was deleted (R12Tail4 and
1/2CSDTail4 in Fig. 5, constructs 12 to 19 in Table 3), the
protein was mainly found in the germinal vesicle (GV). The
absence of the two nuclear localization signals (NLS) in the
second B/A island likely accounts for the presence of con-
structs 15 and 19 in the cytoplasm, as well as the GV. All of
these constructs (12–19) were not retained following per-
meabilization. Moreover, the constructs with mutations in
either of the RNP motifs in the CSD (PM1 in Fig. 4 and
constructs 31 to 33 in Table 3) were also mainly localized to
the GV and soluble. These results demonstrated that MSY2
requires an intact CSD for both cytoplasmic localization and
retention following Triton treatment.
The requirement for an intact CSD was confirmed by the
nuclear localization and solubility of constructs 24 to 28, and
30 (Table 3). Nevertheless, the CSD alone was not sufficient to
retain MSY2 following Triton permeabilization, since the
NCSD or CSD constructs were completely soluble (Fig. 4,
constructs 5 and 11 in Table 3). The presence of at least one
additional B/A island was sufficient to direct cytoplasmic re-
tention of MSY2 (NCSDTail1 in Fig. 4, constructs 1 to 4, 7 to
10 in Table 3). We did not ascertain if the CSD in combination
with another B/A was retained following permeabilization.
Because both CSD and B/A islands of MSY2 are in-
volved in RNA binding, deletion or mutations in either
domain would affect the ability of MSY2 to bind RNA. To
verify that the mutant forms of MSY2 that were not retained
following Triton permeabilization indeed possessed reduced
affinity for RNA, RNA gel mobility shift assays were per-
formed using purified MSY2 recombinant proteins. NCSD
(Table 3, construct 5), which was not retained following
Triton permeabilization, had a markedly reduced affinity for
the Prm1 probe, when compared to MSY2, and only re-
sulted in a slight shift at the highest concentration of NCSD
examined (Fig. 5). The absence of the B/A islands in NCSD
may account for the low-affinity binding to the Prm1 probe,
which contains four consensus MSY2 binding sites (UAC-
CACAUCCACU), since these islands are also involved in
RNA binding and protein–protein interactions (Sommer-
ville, 1999; Sommerville and Ladomery, 1996; Wolffe,
1994). The addition of one B/A island (NCSDTail1, Table
3, construct 4), which was retained following Triton perme-
abilization, resulted in a very similar binding pattern as
Fig. 2. Solubility of MSY2 in mouse male germ cells and somatic cells. (A)
Isolated mouse male germ cells were either resuspended in hypotonic
buffer (Hypo) followed by homogenization or treated with 0.1% Triton
X-100 in the presence or absence of RNasin (0.6 units/l) (T/RNasin).
S, supernatant (6 g); W, wash fraction (6 g); P, pellet (80 g). (B) NIH
3T3 cells were transfected with an MSY2-EGFP-expressing construct and
treated with 0.1 or 0.5% Triton X-100. About 0.3 g protein was loaded in
each lane. Control, EGFP-expressing cells; T, total protein, no centrifuga-
tion; S, supernatant; P, pellet. The faster migrating bands likely represent
degradation products, because they were not detected in the control, EGFP-
expressing cells. The amount of MSY2 present in all protein bands was
used to calculate the relative amount of soluble MSY2. For both panels, the
experiment was performed twice; similar results were obtained each time,
and shown are the results of one experiment.
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Fig. 3. Laser-scanning confocal images of MSY2 in Triton X-100 treated preimplantation embryos. EGFP or MSY2-EGFP chimeric mRNA was
microinjected into one-cell embryos (20 h post hCG), which were then cultured to 30 h post-hCG (late one-cell stage), or 44 h post-hCG (mid two-cell stage).
mRNAs were also microinjected into one blastomere of two-cell embryos (44 h post hCG), which were cultured until 69 h post-hCG to the four-cell stage,
or 78 h post-hCG to the eight-cell stage. The experiment was conducted three times, with at least five embryos per group. Similar results were obtained in
each experiment and shown are representative images. The presence of MSY2-EGFP in the pronuclei following permeabilization was consistently observed.
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wild-type MSY2 (Fig. 5). As previously reported (Yu et al.,
2002), the multiple banding pattern observed with higher
concentrations of input protein likely reflects the binding of
multiple protein molecules to a single RNA molecule.
When RNP1 was mutated in the PM1 protein (Table 3,
construct 31), which was not retained following Triton
permeabilization, the binding affinity for the probe was
substantially reduced (Fig. 5). Thus, there was a good cor-
relation between the ability of MSY2 to bind RNA and its
cytoplasmic retention following permeabilization.
In summary, an intact CSD was required to localize
MSY2 in the oocyte cytoplasm, and the RNA-binding ac-
tivity ascribed to both the CSD and an additional B/A island
were required to retain MSY2 following permeabilization,
i.e., the results were consistent with the second model in
which binding of mRNA to MSY2 leads to its resistance to
detergent extraction.
RNA integrity is required for the insolubility of MSY2
As described above, the observation that deletion/muta-
tions in the CSD or B/A islands resulted in MSY2 being
soluble following permeabilization (Table 3, constructs 31–
33) suggested that RNA binding by MSY2 leads to its
Fig. 4. Subcellular localization of exogenously expressed mutant MSY2-EGFP fusion proteins in fully grown mouse oocytes. (A) Diagram of MSY2
constructs. The N-terminus and cold-shock domain (CSD) contain 88 amino acids (aa) and 82 aa, respectively. The first half of the CSD, CSD1, has 40 aa,
which includes RNP1 and RNP2, while the second half, CSD2, includes the remaining of 42 aa. B/A1 to 4 divides the C-terminal tail domain of MSY2 into
four regions, each of which contains one basic/aromatic amino acid island (B/A). B/A1 has 49 aa: B/A2 has 53 aa: B/A3 contains 46 aa: B/A4 includes the
last 42 aa. PM1 has site-mutations (underlined) in the RNP1 in the CSD (RNP1: NGYGFINR to NGAGAINR). (B) Subcellular localization of mutant
MSY2-EFGP fusion proteins. The mRNAs of various constructs were microinjected into fully grown mouse oocytes, which were then cultured overnight in
presence of IBMX to inhibit maturation. Oocytes were either subjected to confocal microscopy after fixation in 3.7% paraformaldehyde (top row), or after
treatment with 0.1% Triton X-100 followed by fixation in 3.7% paraformaldehyde (bottom row). The experiment was conducted three times, with at least
five embryos per group. Similar results were obtained in each experiment and shown are representative images.
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cytoplasmic localization and insolubility. The presence of
the two NLS in the second B/A domain would account for
the localization in the GV. This model predicts that destroy-
ing the integrity of RNA would result in MSY2 becoming
soluble.
To test this proposal, permeabilized oocytes were incu-
bated with increasing concentrations of RNase A or intact
oocytes were microinjected with RNase A and then perme-
abilized. In either case, RNase A treatment resulted in the
degradation of endogenous maternal mRNAs, as shown in
the decreased levels of the RT-PCR products of spindlin,
Mos, and Plat (Fig. 6A). Following RNase A treatment (or
RNase T1, data not shown), essentially all the endogenous
MSY2 protein was released following permeabilization, as
detected by immunoblotting (Fig. 6B) or laser-scanning
confocal microscopy (Fig. 6C); RNase A treatment also
resulted in the release of MSY2-EGFP in permeabilized
oocytes (data not shown). The loss of immunoreactive
MSY2 could not be due to nonspecific proteolysis, since the
amount of endogenous MSY2 detected by immunoblotting
in the RNase-injected oocytes was similar to noninjected
oocytes (Fig. 6B). Moreover, there was no detectable effect
on actin staining (Fig. 6C). Last, in nonpermeabilized oo-
cytes, MSY2 still displayed a similar subcellular localiza-
tion pattern following RNase treatment. The absence of
MSY2, which contains two functional NLSs, in the GV was
unanticipated since it was soluble following permeabiliza-
tion.
Table 3
Domain structure of constructs and localization prior to and following permeabilizationa
No. Name N CSD1 CSD2 B/A islands Subcellular localizationb Triton treatment
1 2 3 4 Cyto GV Nucleolus Cyto GV
1 MSY2        Yes No No Yes No
2 NCSDTail3       Yes Little No Yes Yes/Noc
3 NCSDTail2      Yes Yes No Yes Yes/No
4 NCSDTail1     Yes Yes No Yes Yes/No
5 NCSD    Yes Yes No No No
6 N-terminus  Yes Yes Yes/No No No
7 CSDTAIL4       Yes No No Yes No
8 CSDTAIL3      Yes Yes No Yes No
9 CSDTAIL2     Yes Yes No Yes Yes/No
10 CSDTAIL1    Yes Yes No Yes Yes/No
11 CSD   Yes Yes No No No
12 1/2CSDTAIL4      No Yes Yes No No
13 1/2CSDTAIL3     No Yes Yes No No
14 1/2CSDTAIL2    No Yes Yes No No
15 1/2CSDTAIL1   Yes Yes Yes No No
16 R12Tail4      Little Yes Yes No No
17 R12Tail3     Little Yes Yes No No
18 R12Tail2    Little Yes Yes Yes No
19 R12Tail1   Yes Yes Yes No No
20 NR12Tail4       Yes Yes Yes Little No
21 NR12Tail3      Yes Yes Yes Little No
22 NR12Tail2     Little Yes No No No
23 NR12Tail1    Yes Little No Yes No
24 NTAIL4      Little Yes Yes No No
25 Tail4     No Yes Yes No No
26 Tail3    Little Yes Yes No No
27 Tail2   Yes Yes Yes No No
28 Tail1  Yes Yes Yes No No
29 CSDTail134      Yes No No Yes No
30 Tail134    Yes Yes No No No
31 PM1  M1d      Little Yes No No No
32 PM2  M2e      Little Yes No No No
33 PM3  M12f      Little Yes No No No
a For each construct, the experiment was repeated three times and at least five oocytes were examined.
b Cyto, cytoplasm; GV, geminal vesicle.
c Yes/No: some oocytes have green fluorescence in the corresponding subcellular compartment, while others do not.
d M1: The construct has mutations in the RNP1 in the cold-shock domain (CSD). RNP1: NGYGFINR to NGAGAINR.
e M2: The construct has mutations in the RNP2 in the cold-shock domain (CSD), RNP2: NDTKED to NATKEA.
f M12: The construct has mutations in both RNP1 and RNP2 in the cold-shock domain (CSD). RNP1: NGYGFINR to NGAGAINR; RNP2: NDTKED
to NATKEA.
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Discussion
MSY2 is one of the most abundant proteins expressed in
the mouse oocyte (Yu et al., 2001). This abundance, cou-
pled with its apparent limited sequence specificity in RNA
binding and modest ability to inhibit translation under in
vitro conditions (Yu et al., 2002), suggests that MSY2 plays
a global role in regulating both mRNA stability and trans-
lation during oocyte growth. Our findings reported here that
in the oocyte the bulk of MSY2 (Yu et al., 2001) and mRNA
(J. Yu, unpublished results) are associated with a Triton-
insoluble fraction provide a mechanism to sequester mRNA
from the translation machinery. This could contribute to the
marked stability of mRNA during oocyte growth, since
translation is linked with mRNA degradation (Peltz et al.,
1992; Sachs, 1993). Interestingly, our data are in agreement
with previous studies indicating that following physical
disruption of oocytes, the bulk of mRNA sediments at low
centrifugal force (9000g) (Bachvarova et al., 1981; Brower
and Schultz, 1982).
Microfilaments and microtubules, two logical cytoskel-
etal systems that could mediate such an interaction with
MSY2, appear not involved. The aminoterminal third of
p50, another Y-box RNA-binding protein, can interact with
actin as detected by a yeast two-hybrid screen, coimmuno-
precipation, cosedimenation with microfilaments, decora-
tion of microfilaments in fiboblasts, and actin-bundling
activity (Ruzanov et al., 1999); tubulin also coimmunopre-
cipitates with p50. In contrast, when the aminoterminal
domain of MSY2 is deleted, the truncated protein is still
retained following permeabilization. Moreover, conditions
that disrupt either the microfilament or the microtubule
networks have little, if any, effect on MSY2 retention fol-
lowing permeabilization.
MSY2 is not retained following permeabilization of ei-
ther male germ cells or somatic cells. Thus, the ability of the
oocyte’s cytoplasm to confer this property appears unique.
This property, however, is lost during preimplantation de-
velopment. Although MSY2 protein is essentially totally
degraded by the late two-cell stage, expression of exoge-
nous MSY2 in later stage embryos by injecting MSY2-
EGFP chimeric mRNA reveals that commencing around the
four-cell stage the expressed protein is mostly soluble fol-
lowing permeabilization, and little, if any, is retained fol-
lowing permeabilization of eight-cell embryos.
The oocyte-specific form of DNA methyltransferase 1,
Dnmt1o (Mertineit et al., 1998), also displays cytoplasmic
retention properties reminescent of MSY2. When Dnmt1o,
which contains a functional NLS (Leonhardt et al., 1992), is
expressed in somatic cells, it localizes to the nucleus, where
DNA methyltransferases are localized (Cardoso and Leon-
hardt, 1999). In contrast, in mouse oocytes Dnmt1o is lo-
calized in the cytoplasm and enriched in the cortex (Carlson
et al., 1992; Doherty et al., 2002). Moreover, it is mostly
insoluble following Triton permeabilization, and this asso-
ciation is not disrupted by either cytochalasin D or nocoda-
zole (Doherty et al., 2002). Nevertheless, there are differ-
ences, the most striking of which is that Dnmt1o is located
and retained in the cytoplasm following permeabilization
throughout preimplantation development, except during the
eight-cell stage when it undergoes a transient nuclear local-
ization (Carlson et al., 1992; Doherty et al., 2002). Thus, the
molecular basis for how oocyte MSY2 (and Dnmt1o) resists
detergent extraction remains enigmatic.
Deletion and mutation analyses reveal that both an intact
CSD and a B/A island are required for cytoplasmic retention
of MSY2 following permeabilization, suggesting that the
RNA-binding activity is required. Reduced RNA binding,
coupled with the presence of an NLS, results in almost
exclusive nuclear localization or both cytoplasmic and nu-
clear localization if an NLS is not present. These results
differ from those obtained from a similar analysis of
FRGY2, which also contains an NLS in the C-terminal tail
domain. When exogenously expressed in Xenopus oocytes,
the tail domain of FRGY2, as well as FRGY2 with muta-
tions in the RNP1 of the CSD, is found only in the cyto-
plasm (Matsumoto et al., 1996). In contrast, when exog-
enously expressed in Xenopus somatic cells, the tail domain
of FRGY2 accumulates in the nuclei (Ranjan et al., 1993).
Thus, the determinants for nuclear vs cytoplasmic localiza-
tion likely differ between mouse and Xenopus oocytes. No
association of FRGY2 with the cytoskeletal fraction of
Xenopus oocytes has been reported.
Cytoplasmic retention of MSY2 following permeabiliza-
tion also requires mRNA integrity, since MSY2 is soluble
following RNase treatment. This suggests that binding of
mRNA by MSY2 results in its conversion, either directly or
indirectly, to a form that resists detergent extraction. Inter-
estingly, MSY2 does not localize to the nucleus following
injection of RNase A even though MSY2 contains two
functional NLSs; mutant forms of MSY2 that should have
reduced RNA-binding activity do localize to the nucleus
when the second B/A island, which contains the NLSs, is
present. One explanation is that MSY2 is still associated
with mRNA fragments following RNase treatment, albeit
Fig. 5. RNA mobility gel shift assays of purified mutant MSY2 recombi-
nant proteins. Full-length Prm1 RNA (435 nt) was used as a probe. MSY2
recombinant proteins contained a His tag at the N-terminus. The amount of
MSY2 protein in the 1, 2, 3, 4, lanes was 0, 1.9, 9.5, and 38.2 pmole,
respectively. The experiment was conducted three times; similar results
were obtained in each case, and shown is a representative experiment.
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the mRNA is degraded and not detected by RT-PCR, and
that the NLS is not functional when MSY2 is associated
with RNA. Alternatively, it is possible that the basis for
MSY2’s retention following permeabilization is that the
MSY2–mRNA complex (likely in association with other
proteins) assembles into a supramolecular network or set of
networks. This network, which appears enriched in the
cortex but extends throughout the cytoplasm, would account
for the observed punctate staining pattern for MSY2 and its
lack of association with either microfilaments and microtu-
bules. Moreover, RNase treatment would be predicted to
disrupt this network, making MSY2 soluble following per-
Fig. 6. The effect of RNase A treatment on the solubility of the endogenous MSY2 protein. (A) Reverse transcription (RT)-PCR analysis of endogenous
mRNAs following RNase A treatment. Rabbit globin mRNA (0.05 pg/oocyte) was added prior to RNA extraction to normalize for RNA extraction and
reverse transcription reaction efficiency. The PCR products were run on a 1.5% agarose gel and stained with ethidium bromide. Lane 1, no treatment; lane
2, oocytes permeabilized with 0.1% Triton X-100; lane 3, oocytes permeabilized with 0.1% Triton X-100 followed by an incubation in ICB buffer at 37°C
for 30 min; lane 4, oocytes permeabilized with 0.1% Triton X-100 followed by an incubation in 50 g/ml RNaseA (in ICB buffer) at 37°C for 30 min; lane
5, oocytes permeabilized with 0.1% Triton X-100 followed by an incubation in 100 g/ml RNase A (in ICB buffer) at 37°C for 30 min; lane 6, no treatment;
lane 7, oocytes microinjected with RNase A; lane 8: oocytes microinjected with RNaseA followed by 0.1% Triton X-100 permeabilization. The experiment
was conducted three times; similar results were obtained each time, and shown are results of a typical experiment. (B) Western blot analysis of endogenous
MSY2 protein from RNase A treated mouse oocytes (30 oocytes/lane). The lane numbers refer to those in (A). (C) Immunofluorescence analysis of MSY2
(top) and actin (bottom). The lane numbers refer to those in (A). The experiment was conducted two times and shown are representative images.
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meabilization. The released components that contain
MSY2, however, would be too large to enter the nucleus.
Although the ability of MSY2 and mRNAs to establish
the proposed network is attractive, it does not account for
the decrease in MSY2 retention following permeabilization
that is observed during preimplantation development. Per-
haps other proteins that associate with MSY2, e.g., MSY4
(Davies et al., 2000), and mRNA, and are required for the
observed insolubility of MSY2, are degraded following
fertilization as is MSY2.
About 25% of MSY2 appears soluble, i.e., it is not
retained following permeabilization. While it is most
likely that mRNAs associated with the insoluble fraction
are not translated and very stable, mRNAs associated
with the soluble fraction could be both translated and
stable. This would contribute to the stability of mRNAs
during oocyte growth, as well as to their ability to be
translated throughout the growth phase. Consistent with
this proposal is that some Y-box proteins are associated
with mRNPs that are present on polysomes, albeit at
lower amounts than in nontranslated mRNPs (Minich et
al., 1993; Minich and Ovchinnikov, 1992), and promote
initiation of translation in vitro at low protein:mRNA
ratios (Evdokimova et al., 1998). Moreover, the CSD of
Y-box proteins stabilizes mRNA via association with the
5 cap of mRNAs (Evdokimova et al., 2001). Our obser-
vation that reducing MSY2 levels in oocytes by a trans-
genic RNA interference (RNAi) approach reduces fecun-
dity implicates a central role of MSY2 in oocyte
development (J. Yu, N.B. Hecht, and R.M. Schultz, un-
published observations) and should provide a suitable
model system to examine the role of MSY2 in the global
regulation of mRNA translation and stability during oo-
cyte growth.
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